|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.4 TWD | +1.00% |
|
+4.11% | +3.75% |
| Mar. 26 | Lukas Biomedical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Lukas Biomedical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Lukas Biomedical Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 184.79 million compared to TWD 157.62 million a year ago. Net loss was TWD 50.07 million compared to TWD 49.49 million a year ago.
Basic loss per share from continuing operations was TWD 1.36 compared to TWD 1.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.75% | 34.02M | |
| -2.54% | 187B | |
| -1.85% | 106B | |
| -4.26% | 66.9B | |
| +1.39% | 49.45B | |
| +16.82% | 48B | |
| +4.06% | 40.84B | |
| +3.49% | 26.48B | |
| +0.65% | 26.25B | |
| +12.96% | 24.62B |
LUKAS BIOMEDICAL INC. 
